MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Volibris 10mg tablets (GlaxoSmithKline UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Volibris 10mg tablets (GlaxoSmithKline UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Volibris 10mg tablets (GlaxoSmithKline UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Volibris 5mg tablets (GlaxoSmithKline UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Volibris 5mg tablets (GlaxoSmithKline UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Volibris 5mg tablets (GlaxoSmithKline UK Ltd).

Stability Notes

Tablet designed to dissolve on tongue - unsuitable for MCA

Provenance

Compatibility recommendation derived from Zofran Melt 4mg oral lyophilisates (Novartis Pharmaceuticals UK Ltd).

Stability Notes

Tablet designed to dissolve on tongue - unsuitable for MCA

Provenance

Recommendation derived from Zofran Melt 8mg oral lyophilisates (Novartis Pharmaceuticals UK Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA, however mitigations may need to be considered.
Medicines under this category are not suitable for use in MCAs.
These medicines have not been reviewed by SPS.